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The association of human papilloma virus (HPV) infection and cervical intraepithelial 
neoplasia (CIN) is well known. Interaction of HPV proteins with cellular regulatory 
proteins leads to up regulation of p16INK4A. The aim of this study was to evaluate 
p16
INK4A protein as a biomarker for CIN lesions and squamous cell carcinoma on biopsy 
specimens of patients who underwent biopsy of the uterine cervix due to abnormal 
cytological finding.  
The authors analyzed biopsies from 50 patients with CIN and invasive squamous cell 
carcinoma of the uterine cervix. Expression of p16
INK4A in CIN and invasive squamous cell 
carcinoma was immunohistochemically analyzed by using monoclonal anti-p16
INK4A 
antibody.  
A total of 50 patients with CIN and invasive squamous cell carcinoma of the uterine 
cervix (mean age 40.2±11.5 years, range 20-74 years) were analyzed. CIN I lesions 
were found in 27 (54%), CIN II/CIN III lesions in 9 (18%), and invasive squamous cell 
carcinoma in 14 (28%) patients. Differences in the expression of p16
INK4A between CIN I, 
CIN II/CIN III and squamous cell carcinoma were statistically significant (p<0.0001). 
Expression of p16INK4A showed low sensitivity (7%), specificity (8%), positive 
predictive value (8%), and negative predictive value (7%) for CIN I. Sensitivity, 
specificity, positive predictive value, and negative predictive value of p16
INK4A were 78%, 
61%, 30%, and 93% for CIN II/CIN III, and 100%, 75%, 61%, and 100% for squamous 
cell carcinoma, respectively. 
Results of this study suggest that p16
INK4A protein may be a sensitive biomarker for 
CIN II/CIN III lesions and invasive squamous cell carcinoma of the uterine cervix. Acta 
Medica Medianae 2011;50(2):29-33. 
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Introduction 
 
The incidence and mortality rate for 
cervical cancer has dramatically declined since 
the introduction of cytological screening by using 
the Papanicolaou (Pap) test (1). The Bethesda 
System for interpretation of Pap smear findings 
has established more uniform diagnostic criteria 
and reduced interpretational errors in cervical 
cytology (2). 
The last revision of the Bethesda System 
differentiates four categories of cervical squamous 
cells abnormalities, including atypical squamous 
cells (ASC), low-grade squamous intraepithelial 
lesions (LSIL), high-grade squamous intraepithelial 
lesions (HSIL), and squamous cell carcinoma (2). 
In histopathology, the cervical intraepithelial 
neoplasia (CIN) terminology divides precursors of 
the squamous cell carcinoma into three groups: 
CIN I, CIN II, and CIN III. Actually, LSIL corresponds 
to CIN I lesion, and HSIL corresponds to both CIN 
II and CIN III lesions (3). 
Human papilloma virus (HPV) is the most 
important etiologic agent in the pathogenesis of 
CIN lesions and cervical carcinoma. It has 
recently been shown that persistent HPV infection 
is necessary for morphological changes in the 
squamous cells of the uterine cervix (4). 
Integration of HPV DNA into the genome of 
cervical epithelial cells may lead to an abnormal 
expression of some cellular proteins such as 
p16
INK4A. It is considered that p16
INK4A is a 
surrogate marker for HPV types of high oncogenic 
risk and the overexpression of p16
INK4A is 
established in CIN lesions and invasive cervical 
carcinoma (5-10).  
The aim of this study was to evaluate 
p16
INK4A protein as a biomarker for CIN lesions 
and squamous cell carcinoma on biopsy specimens 
of patients who underwent biopsy of the uterine 
cervix due to abnormal cytological finding. 
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Patients and methods 
 
A retrospective study was conducted in 50 
patients with cytological diagnoses of ASC-US, 
LSIL, HSIL and invasive squamous cell carcinoma, 
who underwent colposcopy and punch biopsy of 
the uterine cervix at the Clinic of Gynecology and 
Obstetrics in Niš, between January 2008 and 
December 2010. 
Cytological findings of the patients were 
classified according to the 2001 Bethesda System 
(3).  
Histopathological analysis of routinely processed 
cervical specimens stained with standard hemato-
xylin-eosin method and immunohistochemical analysis 
of p16
INK4A were done at the Institute of Pathology, 
Faculty of Medicine, University of Niš.  
For p16
INK4A detection, a mouse monoclonal 
anti-p16
INK4A antibody (clone 6H12, IgG2b / Newcastle) 
at a dilution of 1:40 and a standard avidin-biotin 
immunoperoxidase complexes detection system 
according to the manufacturer's protocol (Dako 
LSAB2R system-HRP) were used. 
Immunohistochemical reaction for p16
INK4A 
protein was present in the nuclei and/or 
cytoplasm of cells. The evaluation of p16
INK4A 
protein expression was performed only in the 
nuclei of cells. Immunohistochemical findings 
were classified as p16
INK4A negative (if ≤10% of 
the nuclei were stained) or p16
INK4A positive (if 
>10% of the nuclei were stained). 
The statistical analysis was performed by 
using Excel 2000 and Statcal. The results were 
presented as average, standard deviation, 
interval of variation (minimum-maximum) and 
index of structure (%). Chi-square test was used 
for the evaluation of significance of determined 
differences for attributive features. Differences 
were considered significant at p < 0,05. 
The values for sensitivity, specificity, positive 
predictive value and negative predictive value of 
immunohistochemical findings in relation to the 
histopathological findings were determined as 
follows: sensitivity = true positive / (true positive 
+ false negative), specificity = true negative / (true 
negative + false positive), positive predictive value 
= true positive / (true positive + false positive) and 
negative predictive value = true negative results / 
(true negative + false negative). 
 
Results 
 
A total of 50 patients aged from 20 to 74 
years were examined. The mean age of patients 
was 40,2±11,5 years.  
Table 1 shows the distribution of cytological 
and histopathological findings. Cytological finding 
were classified as ASC-US in 5 (10%) patients. 
LSIL (CIN I) lesions were found in 20 (40%) 
patients after cytological examination and 27 
(54%) patients after histopathological examination. 
In 18 (36%) patients, HSIL lesions were cytologically 
verified and in 9 (18%) patients HSIL (CIN II/CIN 
III) lesions were histopathologically verified. 
Squamous cell carcinoma was found in 7 (14%) 
patients after cytological examination and 14 
(28%) patients after histopathological exami-
nation. 
Immunohistochemical analysis revealed a 
positive nuclear expression of p16
INK4A in 7,41% 
of CIN I (LSIL) lesions, 77,78% of CIN II/CIN III 
(HSIL) lesions and 100% of squamous cell carcinomas 
(Figures 1-3, Table 2). These differences were 
statistically significant (χ2 test, p<0,0001). 
 
Table 1. Cytological and histopathological finding 
 
Finding   N (%) 
Cytological finding   
ASC-US   5 (10) 
LSIL  20 (40) 
HSIL  18 (36) 
Carcinoma   7 (14) 
Histopathological finding   
CIN I (LSIL)  27 (54) 
CIN II/CIN III (HSIL)   9 (18) 
Carcinoma  14 (28) 
ASC-US – atypical squamous cells of undetermined 
significance; 
LSIL - low grade squamous intraepithelial lesion;  
HSIL - high grade squamous intraepithelial lesion;  
CIN – cervical intraepithelial neoplasia 
 
Table 2. Histopathological finding and 16
INK4A expression  
 
p16
 INK4A expression   χ
2 test  Histo- 
pathological 
finding   N 
Positive 
N (%) 
Negative 
N (%) 
(p) 
CIN I (LSIL)  27 
2 
(7,41) 
25 
(92,59) 
CIN II/CIN III 
(HSIL) 
9 
7 
(77,78) 
2 
(22,22) 
Carcinoma 14 
14 
(100) 
0 
(0) 
<0.0001 
Total 50 
23 
(46) 
27 
(54) 
 
LSIL - low grade squamous intraepithelial lesion;  
HSIL - high grade squamous intraepithelial lesion; 
CIN – cervical intraepithelial neoplasia 
 
Table 3. Sensivity, specificity, positive predictive value, 
and negative predictive value of p16
INK4A depending on 
the histopathological diagnosis 
 
Histopathological diagnosis  
  LSIL  
(CIN I) 
N=27 
HSIL 
(CIN 
II/CIN III) 
N=9 
Carcinoma 
 
N=14 
Sensivity   7%  78% 100% 
Specificity   8%  61%  75% 
Positive predictive 
value  
8% 30%  61% 
Negative predictive 
value 
7% 93%  100% 
LSIL - low grade squamous intraepithelial lesion;  
HSIL - high grade squamous intraepithelial lesion;  
CIN – cervical intraepithelial neoplasia Acta Medica Medianae 2011, Vol.50(2)                                                  Evaluation of P16
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Figure 1. Negative expression of p16
INK4A in CIN I lesion 
(LSAB, x400) 
 
 
 
Figure 2. Positive expression of p16
INK4A in CIN III lesion 
(LSAB, x400) 
 
 
 
Figure 3. Positive expression of p16I
NK4A in squamous 
cell carcinoma (LSAB, x400) 
 
Table 3 shows values for sensitivity, 
specificity, positive predictive value and negative 
predictive value of p16
INK4A, depending on the 
histopathological diagnosis. Expression of p16
INK4A 
showed low sensitivity (7%), specificity (8%), 
positive predictive value (8%) and negative 
predictive value (7%) for CIN I (LSIL) lesions. In  
contrast, the sensitivity, specificity, positive 
predictive value and negative predictive value of 
p16
INK4A were 78%, 61%, 30% and 93% for CIN 
II/CIN III (HSIL) lesions and 100%, 75%, 61% 
and 100% for invasive squamous cell carcinoma.  
 
Discussion  
 
The occurrence of invasive squamous cell 
carcinoma of the uterine cervix is preceded by 
precancerous lesions, which are termed cervical 
intraepithelial neoplasia (CIN). According to the 
severity, CIN lesions are divided into CIN I, CIN 
II and CIN III. It is now believed that CIN II and 
CIN III lesions occur as a result of a persistent 
infection with HPV types of high oncogenic risk, 
but also in presence of bacterial vaginosis (11). 
In persistent HPV infections, HPV DNA was 
integrated into the host DNA (4). Integration of 
viral DNA into the genome of cervical epithelial 
cells leads to abnormal expression of several 
cellular proteins. One of them is p16
INK4A protein 
that regulates cell cycle. 
There are different data regarding the 
expression of p16
INK4A in CIN lesions and invasive 
cervical carcinoma (12-29). According to the 
data, p16
INK4A is expressed in 0-100% of LSIL 
(CIN I) lesions, 45-100% of HSIL (CIN II/CIN III) 
lesions and 93-100% of invasive cervical 
carcinoma. In this study, p16
INK4A expression was 
found in 77,78% of HSIL (CIN II/CIN III) lesions 
and 100% of invasive squamous cell carcinoma 
of the uterine cervix. Also, expression of p16
INK4A 
was found in 7,41% of LSIL (CIN I) lesions. 
Similar results were registered by Haidopoulos et 
al. (27), who found expression of p16
 INK4A in 
6,07%of LSIL lesions. 
In this study, the sensitivity of p16
INK4A 
expression in detecting of CIN II/CIN III lesions 
and invasive squamous cell carcinoma of the 
uterine cervix was high (75% for CIN II/CIN III 
lesions and 100% for invasive squamous cell 
carcinoma). In contrast, the sensitivity of p16
INK4A 
expression in detecting of CIN I lesions was low 
(7%). The specificity of p16
INK4A expression for 
CIN I lesions, CIN II/CIN III lesions and invasive 
squamous cell carcinoma was 8%, 61% and 
75%, respectively. The positive predictive value 
of p16
INK4A expression was 8% for CIN I lesions, 
30% for CIN II/CIN III lesions and 61% for 
invasive squamous cell carcinoma. The negative 
predictive value of p16
INK4A expression for CIN I 
lesions, CIN II/CIN III lesions and invasive 
squamous cell carcinoma of uterine cervix was 
7%, 93% and 100%, respectively. 
 
Conclusion  
 
Based on the results of this study, it was 
concluded that p16
INK4A protein may be a 
sensitive biomarker for CIN II/CIN III lesions and 
invasive squamous cell carcinoma of the uterine 
cervix. 
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EVALUACIJA P16
INK4A PROTEINA KAO BIOMARKERA ZA 
CERVIKALNU INTRAEPITELNU NEOPLAZIJU I SKVAMOCELULARNI 
KARCINOM GRLIĆA MATERICE 
 
Biljana Đorđević i Nikola Živković 
 
 
  Udruženost infekcije humanim papiloma virusima (HPV) i cervikalne intraepitelne 
neoplazije (CIN) dobro je poznata. Interakcija HPV proteina sa ćelijskim regulatornim 
proteinima dovodi do ushodne regulacije 16
INK4A. Cilj rada bila je evaluacija p16INK4 
proteina kao biomarkera za CIN lezije i skvamocelularni karcinom na biopsijskim 
uzorcima bolesnica koje su bile podvrgnute biopsiji grlića materice zbog nenormalnog 
citološkog nalaza.  
Autori su analizirali biopsijske uzorke 50 bolesnica sa CIN lezijama i invazivnim 
skvamocelularnim karcinomom grlića materice. Ekspresija p16
INK4A u CIN lezijama i 
invazivnom skvamocelularnom karcinomu grlića materice analizirana je imunohisto-
hemijski upotrebom monoklonskog anti- p16
INK4A antitela.  
Analizirano je ukupno 50 bolesnica sa CIN lezijama i invazivnim skvamocelularnim 
karcinomom grlića materice prosečnog starosnog doba 40.2±11.5 godina (opseg 20-74 
godine). CIN I lezije nađene su kod 27 (54%), CIN II/CIN III lezije kod 9 (18%) i 
invazivni skvamocelularni karcinom kod 14 (28%) bolesnica. Razlike u ekspresiji p16
INK4A 
između CIN I lezija, CIN II/CIN III lezija i invazivnog skvamocelularnog karcinoma bile 
su statistički značajne (p<0.0001). Ekspresija p16INK4A pokazivala je nisku senzitivnost 
(7%), specifičnost (8%), pozitivnu prediktivnu vrednost (8%) i negativnu prediktivnu 
vrednost (7%) za CIN I. Senzitivnost, specifičnost, pozitivna prediktivna vrednost i 
negativna prediktivna vrednost p16
INK4A iznosile su 78%, 61%, 30% i 93% za CIN II/CIN 
III i 100%, 75%, 61% i 100% za skvamocelularni karcinom. 
Rezultati ove studije ukazuju da p16
INK4A protein može biti senzitivni biomarker za 
CIN II/CIN III lezije i invazivni skamocelularni karcinom grlića materice. Acta Medica 
Medianae 2011;50(2):29-33. 
 
Ključne reči: cerviklna intraepitelna neoplazija, skvamocelularni karcinom, p16
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